Use the table below to compare gene contents and ordering recommendations for select ARUP hereditary cancer panels. For additional test options, refer to the Laboratory Test Directory.
Filter by genes to identify relevant ARUP tests. Click on gene or test titles to display additional details. Please note: These features are optimized for use on a desktop platform. Some functionality may not be available on mobile.
Please note the following indications for genetic testing:
- Testing minors for adult-onset conditions is not recommended; testing will not be performed in minors without prior approval.
- If a familial variant has previously been identified, testing should be performed for that specific variant using Familial Targeted Sequencing 3005867.
- For additional information, please contact an ARUP genetic counselor at 800-242-2787 ext. 2141.
Filter gene rows Test Gene Filter ARUP tests |
Hereditary Cancer Panel 2012032
|
Hereditary Breast and Gynecological Panel 2012026
|
Hereditary Breast Cancer Guidelines‐Based Panel 3005654
|
Hereditary Breast Cancer High‐Risk Panel 3005632
|
BRCA1 and BRCA2‐Associated HBOC Syndrome Panel 3001855
|
Hereditary Gastrointestinal Cancer Panel 2013449
|
Hereditary Gastric Cancer Panel, Sequencing and Deletion/Duplication 3005963
|
Hereditary Gastrointestinal Cancer High‐Risk Panel 3005697
|
Lynch Syndrome Panel 3001605
|
APC‐ and MUTYH‐Associated Polyposis Panel 3004407
|
Hereditary Central Nervous System Cancer Panel, Sequencing and Deletion/Duplication 3001633
|
Hereditary Renal Cancer Panel 2010214
|
Hereditary Pancreatic Cancer Panel 3005708
|
Hereditary Prostate Cancer Panel 3005686
|
Hereditary Melanoma Panel, Sequencing and Deletion/Duplication 3002673
|
Hereditary Paraganglioma‐Pheochromocytoma Expanded Panel, Sequencing and Deletion/Duplication 3005912
|
Hereditary Paraganglioma‐Pheochromocytoma (SDHA, SDHB, SDHC, and SDHD) Sequencing and Deletion/Duplication 3004480
|
Hereditary Thyroid Cancer Panel, Sequencing and Deletion/Duplication 3005944
|
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ALK 105590 ALK-related neuroblastic tumor susceptibility |
✔ | ✔ | ||||||||||||||||
APC 611731 Familial adenomatous polyposis (FAP) |
✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ||||||||||
ATM 607585 Breast, colorectal, ovarian, pancreatic, prostate Inheritance: Autosomal dominant |
✔ | ✔ | ✔ | ✔ | ✔ | |||||||||||||
AXIN2 604025 Oligodontia-colorectal cancer syndrome (ODCRCS) |
✔ | ✔ | ||||||||||||||||
BAP1 603089 BAP1 tumor predisposition syndrome (BAP1-TPDS) |
✔ | ✔ | ✔ | |||||||||||||||
BARD1 601593 Breast Inheritance: Autosomal dominant |
✔ | ✔ | ✔ | |||||||||||||||
BMPR1A 601299 Juvenile polyposis syndrome (JPS) |
✔ | ✔ | ✔ | |||||||||||||||
BRCA1 113705 Hereditary breast and ovarian cancer (HBOC) syndrome |
✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | |||||||||||
BRCA2 600185 Hereditary breast and ovarian cancer (HBOC) syndrome |
✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ||||||||||
BRIP1 605882 Breast, ovarian Inheritance: Autosomal dominant |
✔ | ✔ | ||||||||||||||||
CDC73 607393 CDC73-related disorders |
✔ | |||||||||||||||||
CDH1 192090 Hereditary diffuse gastric cancer (HDGC) |
✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ||||||||||||
CDK4 123829 Cutaneous melanoma, pancreatic Inheritance: Autosomal dominant |
✔ | ✔ | ✔ | |||||||||||||||
CDKN1B 600778 Multiple endocrine neoplasia (MEN) Type 4 |
✔ | |||||||||||||||||
CDKN2A 600160 Familial atypical multiple mole melanoma-pancreatic carcinoma (FAMMM-PC) syndrome (also known as melanoma-pancreatic cancer syndrome) |
✔ | ✔ | ✔ | |||||||||||||||
CHEK2 604373 Breast, colorectal, prostate, thyroid Inheritance: Autosomal dominant |
✔ | ✔ | ✔ | ✔ | ✔ | |||||||||||||
CTNNA1 116805 Breast, stomach Inheritance: Autosomal dominant |
✔ | ✔ | ||||||||||||||||
DICER1 606241 DICER1-related disorders |
✔ | ✔ | ✔ | ✔ | ✔ | |||||||||||||
EGFR 131550 Lung Inheritance: Autosomal dominant |
✔ | |||||||||||||||||
EPCAM 185535 Lynch syndrome/hereditary nonpolyposis colorectal cancer (HNPCC) |
✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ||||||||
FH 136850 FH tumor predisposition syndrome/hereditary leiomyomatosis and renal cell cancer (HLRCC) |
✔ | ✔ | ✔ | |||||||||||||||
FLCN 607273 Birt-Hogg-Dubé syndrome (BHDS) |
✔ | ✔ | ||||||||||||||||
HOXB13 604607 Prostate Inheritance: Autosomal dominant |
✔ | ✔ | ||||||||||||||||
HRAS 190020 Costello syndrome |
✔ | ✔ | ||||||||||||||||
KIT 164920 Gastrointestinal stromal tumor (GIST) Inheritance: Autosomal dominant |
✔ | ✔ | ||||||||||||||||
LZTR1 600574 Schwannomatosis Inheritance: Autosomal dominant |
✔ | ✔ | ||||||||||||||||
MAX 154950 Hereditary paraganglioma-pheochromocytoma (HPP) syndromes |
✔ | ✔ | ||||||||||||||||
MC1R 155555 Cutaneous melanoma Inheritance: Autosomal dominant |
✔ | ✔ | ||||||||||||||||
MEN1 613733 Multiple endocrine neoplasia type 1 (MEN1) |
✔ | ✔ | ✔ | ✔ | ✔ | |||||||||||||
MET 164860 Hereditary papillary renal cell carcinoma (HPRCC) |
✔ | ✔ | ||||||||||||||||
MITF 156845 Waardenburg syndrome type II |
✔ | ✔ | ||||||||||||||||
MLH1 120436 Lynch syndrome/hereditary nonpolyposis colorectal cancer (HNPCC) |
✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ||||||||
MLH3 120436 MLH3-associated polyposis |
✔ | ✔ | ||||||||||||||||
MSH2 609309 Lynch syndrome/hereditary nonpolyposis colorectal cancer (HNPCC) |
✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ||||||||
MSH3 600887 Colorectal, polyposis Inheritance: Autosomal dominant |
✔ | ✔ | ||||||||||||||||
MSH6 600678 Lynch syndrome/hereditary nonpolyposis colorectal cancer (HNPCC) |
✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ||||||||
MUTYH 604933 Breast, colorectal Inheritance: Autosomal dominant |
✔ | ✔ | ✔ | ✔ | ||||||||||||||
NBN 602667 Breast, ovarian, prostate Inheritance: Autosomal dominant |
✔ | ✔ | ✔ | |||||||||||||||
NF1 613113 Neurofibromatosis type 1 (NF1) |
✔ | ✔ | ✔ | ✔ | ✔ | |||||||||||||
NF2 607379 Neurofibromatosis type 2 (NF2) |
✔ | ✔ | ||||||||||||||||
NTHL1 602656 Colorectal, polyposis Inheritance: Autosomal recessive |
✔ | ✔ | ||||||||||||||||
PALB2 610355 Breast, ovarian, pancreas, prostate Inheritance: Autosomal dominant |
✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ||||||||||||
PDGFRA 173490 Gastrointestinal stromal tumor (GIST), inflammatory fibroid polyp, fibroid tumor Inheritance: Autosomal dominant |
✔ | ✔ | ||||||||||||||||
PMS2 600259 Lynch syndrome/hereditary nonpolyposis colorectal cancer (HNPCC) |
✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ||||||||
POLD1 174761 Polymerase proofreading-associated polyposis (PPAP) |
✔ | ✔ | ||||||||||||||||
POLE 174762 Polymerase proofreading-associated polyposis (PPAP) |
✔ | ✔ | ||||||||||||||||
POT1 606478 POT1 tumor predisposition syndrome |
✔ | ✔ | ✔ | |||||||||||||||
PRKAR1A 188830 Carney complex |
✔ | ✔ | ✔ | |||||||||||||||
PTCH1 601309 Nevoid basal cell carcinoma syndrome (NBCCS)/Gorlin syndrome |
✔ | ✔ | ||||||||||||||||
PTEN 601728 Cowden syndrome/PTEN hamartoma tumor syndrome |
✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | |||||||||
RAD51C 602774 Breast, ovarian Inheritance: Autosomal dominant |
✔ | ✔ | ||||||||||||||||
RAD51D 602954 Breast, ovarian, prostate Inheritance: Autosomal dominant |
✔ | ✔ | ✔ | |||||||||||||||
RB1 614041 Hereditary retinoblastoma |
✔ | ✔ | ||||||||||||||||
RECQL 600537 Breast Inheritance: Autosomal dominant |
✔ | ✔ | ||||||||||||||||
RET 164761 Multiple endocrine neoplasia 2 (MEN2) |
✔ | ✔ | ✔ | |||||||||||||||
SDHA 600857 Hereditary paraganglioma-pheochromocytoma (HPP) syndromes |
✔ | ✔ | ✔ | ✔ | ✔ | |||||||||||||
SDHAF2 613019 Hereditary paraganglioma-pheochromocytoma (HPP) syndromes |
✔ | ✔ | ||||||||||||||||
SDHB 185470 Hereditary paraganglioma-pheochromocytoma (HPP) syndromes |
✔ | ✔ | ✔ | ✔ | ✔ | |||||||||||||
SDHC 602413 Hereditary paraganglioma-pheochromocytoma (HPP) syndromes |
✔ | ✔ | ✔ | ✔ | ✔ | |||||||||||||
SDHD 602690 Hereditary paraganglioma-pheochromocytoma (HPP) syndromes |
✔ | ✔ | ✔ | ✔ | ✔ | |||||||||||||
SMAD4 600993 Juvenile polyposis syndrome (JPS), hereditary hemorrhagic telangiectasia (HHT) syndrome |
✔ | ✔ | ✔ | |||||||||||||||
SMARCA4 603254 Coffin-Siris syndrome, rhabdoid tumor predisposition syndrome (RTPS) |
✔ | ✔ | ✔ | ✔ | ||||||||||||||
SMARCB1 601607 Coffin-Siris syndrome, rhabdoid tumor predisposition syndrome (RTPS) |
✔ | ✔ | ✔ | |||||||||||||||
SMARCE1 603111 Coffin-Siris syndrome |
✔ | ✔ | ||||||||||||||||
STK11 602216 Peutz-Jeghers syndrome (PJS) |
✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ||||||||||||
SUFU 607035 Nevoid basal cell carcinoma syndrome (NBCCS)/Gorlin syndrome |
✔ | ✔ | ||||||||||||||||
TERT 187270 Dyskeratosis congenita |
✔ | ✔ | ||||||||||||||||
TMEM127 613403 Hereditary paraganglioma-pheochromocytoma (HPP) syndromes |
✔ | ✔ | ||||||||||||||||
TP53 191170 Li-Fraumeni syndrome (LFS) |
✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ||||||
TSC1 605284 Tuberous sclerosis complex (TSC) |
✔ | ✔ | ✔ | |||||||||||||||
TSC2 191092 Tuberous sclerosis complex (TSC) |
✔ | ✔ | ✔ | |||||||||||||||
VHL 608537 Von Hippel-Lindau (VHL) syndrome |
✔ | ✔ | ✔ | ✔ | ✔ | |||||||||||||
WT1 607102 WT1 disorder |
✔ | |||||||||||||||||
Recommended test to confirm a hereditary cause of cancer in individuals with a personal or family history consistent with features of more than one cancer syndrome. Testing minors for adult-onset conditions is not recommended; testing will not be performed in minors without prior approval. For additional information, please contact an ARUP genetic counselor at 800-242-2787 ext. 2141. |
Recommended test to confirm a hereditary cause of breast and/or gynecological cancer(s) in individuals with a complex personal or family history of breast, ovarian, or endometrial cancer. Testing minors for adult-onset conditions is not recommended; testing will not be performed in minors without prior approval. For additional information, please contact an ARUP genetic counselor at 800-242-2787 ext. 2141. |
Germline analysis of moderate and high lifetime risk (>15%) hereditary breast cancer genes (including BRCA1 and BRCA2) for individuals with personal or family history of hereditary breast or other related cancers. Testing minors for adult-onset conditions is not recommended; testing will not be performed in minors without prior approval. For additional information, please contact an ARUP genetic counselor at 800-242-2787 ext. 2141. |
Germline analysis of high lifetime risk (>40%) hereditary breast cancer genes (including BRCA1 and BRCA2) for individuals with personal or family history of hereditary breast or other related cancers. Testing minors for adult-onset conditions is not recommended; testing will not be performed in minors without prior approval. For additional information, please contact an ARUP genetic counselor at 800-242-2787 ext. 2141. |
Recommended test to confirm BRCA1- and BRCA2-associated hereditary breast and ovarian cancer (HBOC) syndrome. Testing minors for adult-onset conditions is not recommended; testing will not be performed in minors without prior approval. For additional information, please contact an ARUP genetic counselor at 800-242-2787 ext. 2141. |
Recommended test to confirm a hereditary cause of gastrointestinal (GI) cancer in individuals with a personal or family history of GI cancer and/or polyposis. Testing minors for adult-onset conditions is not recommended; testing will not be performed in minors without prior approval. For additional information, please contact an ARUP genetic counselor at 800-242-2787 ext. 2141. |
Recommended test to confirm a hereditary cause of gastric cancer in individuals with a personal or family history of disease. Testing minors for adult-onset conditions is not recommended; testing will not be performed in minors without prior approval. For additional information, please contact an ARUP genetic counselor at 800-242-2787 ext. 2141.
|
Germline analysis of genes associated with high-risk hereditary colorectal cancer syndromes, including Lynch syndrome, familial adenomatous polyposis (FAP) or another APC-associated polyposis condition, and MUTYH-associated polyposis (MAP). Testing minors for adult-onset conditions is not recommended; testing will not be performed in minors without prior approval. For additional information, please contact an ARUP genetic counselor at 800-242-2787 ext. 2141. |
Recommended test to confirm a diagnosis of Lynch syndrome (LS) for individuals with a personal and/or family history consistent with LS. Testing minors for adult-onset conditions is not recommended; testing will not be performed in minors without prior approval. For additional information, please contact an ARUP genetic counselor at 800-242-2787 ext. 2141. |
Recommended diagnostic or predictive test for APC-associated polyposis conditions (familial adenomatous polyposis [FAP], attenuated familial adenomatous polyposis [AFAP], gastric adenocarcinoma and proximal polyposis of the stomach [GAPPS]), and MUTYH-associated polyposis (MAP). Testing minors for adult-onset conditions is not recommended; testing will not be performed in minors without prior approval. For additional information, please contact an ARUP genetic counselor at 800-242-2787 ext. 2141. |
Recommended test to confirm a hereditary cause of central nervous system (CNS) cancer in individuals with a personal or family history. Testing minors for adult-onset conditions is not recommended; testing will not be performed in minors without prior approval. For additional information, please contact an ARUP genetic counselor at 800-242-2787 ext. 2141. |
Recommended test to confirm hereditary cause of renal cancer in individuals with a personal or family history. Testing minors for adult-onset conditions is not recommended; testing will not be performed in minors without prior approval. For additional information, please contact an ARUP genetic counselor at 800-242-2787 ext. 2141. |
Recommended test to confirm a hereditary cause of pancreatic cancer in individuals with a personal or family history. Testing minors for adult-onset conditions is not recommended; testing will not be performed in minors without prior approval. For additional information, please contact an ARUP genetic counselor at 800-242-2787 ext. 2141. |
Recommended test to confirm a hereditary cause of prostate cancer in individuals with a personal or family history. Testing minors for adult-onset conditions is not recommended; testing will not be performed in minors without prior approval. For additional information, please contact an ARUP genetic counselor at 800-242-2787 ext. 2141. |
Recommended test to confirm a hereditary cause of melanoma in individuals with a personal or family history of disease. Testing minors for adult-onset conditions is not recommended; testing will not be performed in minors without prior approval. For additional information, please contact an ARUP genetic counselor at 800-242-2787 ext. 2141. |
Recommended test to confirm a clinical diagnosis or family history of a hereditary paraganglioma-pheochromocytoma (PGL/PCC) syndrome. |
Use for germline analysis of genes associated with most common paraganglioma-pheochromocytoma syndromes. |
Recommended test to confirm a hereditary cause of thyroid cancer in individuals with a personal or family history of thyroid cancer. |
|
For more detailed test information such as limitations and contraindications, see the Test Fact Sheet. |
For more detailed test information such as limitations and contraindications, see the Test Fact Sheet. |
For more detailed test information such as limitations and contraindications, see the Test Fact Sheet. |
For more detailed test information such as limitations and contraindications, see the Test Fact Sheet. |
For more detailed test information such as limitations and contraindications, see the Test Fact Sheet. |
For more detailed test information such as limitations and contraindications, see the Test Fact Sheet. |
For more detailed test information such as limitations and contraindications, see the Test Fact Sheet |
For more detailed test information such as limitations and contraindications, see the Test Fact Sheet. |
For more detailed test information such as limitations and contraindications, see the Test Fact Sheet. *Deletion/duplication only; sequencing is not available for this gene. |
For more detailed test information such as limitations and contraindications, see the Test Fact Sheet. |
For more detailed test information such as limitations and contraindications, see the Test Fact Sheet. |
For more detailed test information such as limitations and contraindications, see the Test Fact Sheet. |
For more detailed test information such as limitations and contraindications, see the Test Fact Sheet. |
For more detailed test information such as limitations and contraindications, see the Test Fact Sheet. |
For more detailed test information such as limitations and contraindications, see the Test Fact Sheet. |
For more detailed test information such as limitations and contraindications, see the Test Fact Sheet. |
For more detailed test information such as limitations and contraindications, see the Test Fact Sheet. |
For more detailed test information such as limitations and contraindications, see the Test Fact Sheet. |
|
Nothing matches your criteria |